Crinetics Approach

News Releases

News Releases

January 2, 2018
Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
SAN DIEGO – January 2, 2018  – Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced that Scott Struthers, Ph.D., founder and chief executive officer, will present at the 36th Annual J.P.